Table 1

Frequency and characteristics of baseline tophi for patients in the randomized trials
Characteristics Pegloticase biweekly Pegloticase monthly Placebo
(n = 85) (n = 84) (n = 43)
Patients with one or more baseline tophi, n (%) 62 (73) 64 (76) 29 (67)
Total number of measurable baseline tophi 159 142 83
Median target area of measurable target tophi, mm2 (range) 378 (25 to 4,080) 377 (25 to 10,625) 460 (30 to 6,230)

Baraf et al.

Baraf et al. Arthritis Research & Therapy 2013 15:R137   doi:10.1186/ar4318

Open Data